Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesIs the metalloendopeptidase EC3.4.24.15 (EP24.15), the enzyme that cleaves luteinizing hormone-releasing hormone, an activating enzyme
Journals of Reproduction and Fertility, 09/16/09
Wu J et al. – Luteinizing hormone–releasing hormone (LHRH) was first isolated in the mammalian hypothalamus and shown to be the primary regulator of the reproductive neuroendocrine axis comprising of the hypothalamus, pituitary and gonads (HPG). LHRH acts centrally through its initiation of pituitary gonadotropin release.
Related Articles
Luteinizing hormone-releasing hormone agonists in the treatment of breast cancer
Expert Opinion in Pharmacotherapy, 10/19/09
Relevance Score: 81%
The Common Genetic Variant of Luteinizing Hormone Has a Longer Serum Half-Life than the Wild Type in Heterozygous Women
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Relevance Score: 66%
Normal Spermatogenesis in a Man with Mutant Luteinizing Hormone
New England Journal of Medicine, 11/05/09
Relevance Score: 66%
Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist
Fertility and Sterility, 10/12/09
Relevance Score: 66%
Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09
Relevance Score: 65%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Continuous infusion of 17-hydroxyprogesterone caproate into either the fetoplacental or intervillous circulation of a placental cotyledon attenuates vasoconstriction of the fetoplacental arteries by thromboxane mimetic U46619
American Journal of Obstetrics and Gynecology, 12/17/09
The Influence of Phototherapy on Serum Cytokine Concentrations in Newborn Infants
American Journal of Perinatology, 12/17/09
N-terminal pro-B-type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia in Premature Infants
American Journal of Perinatology, 12/17/09
Today in Repro Endo - Infertility...keeping you current
Receive free subspecialty "5-minute updates" via email
Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)
Human Reproduction, 12/17/09
Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy
Human Reproduction, 12/17/09
Does erythropoietin affect motility of spermatozoa
Archives of Gynecology and Obstetrics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor